MRSIX vs. MEDIX

Last updated Jun 4, 2026

MRSIX (MFS Research International Fund) and MEDIX (MFS Emerging Markets Debt Fund) are both mutual funds - MRSIX is a Foreign Large Cap Equities fund managed by MFS, while MEDIX is a Emerging Markets Bonds fund managed by MFS. Over the past 10 years, MRSIX returned 8.71%/yr vs 3.73%/yr for MEDIX. At a 0.36 correlation, their price movements are largely independent. MRSIX charges 0.76%/yr vs 0.81%/yr for MEDIX.

Performance

MRSIX vs. MEDIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MFS Research International Fund (MRSIX) and MFS Emerging Markets Debt Fund (MEDIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MRSIX achieves a 8.90% return, which is significantly higher than MEDIX's 2.46% return. Over the past 10 years, MRSIX has outperformed MEDIX with an annualized return of 8.71%, while MEDIX has yielded a comparatively lower 3.73% annualized return.

MRSIX

• 1D: 0.61%
• 1M: 3.58%
• YTD: 8.90%
• 6M: 11.09%
• 1Y: 16.77%
• 3Y*: 12.87%
• 5Y*: 5.79%
• 10Y*: 8.71%

MEDIX

• 1D: 0.16%
• 1M: 1.09%
• YTD: 2.46%
• 6M: 3.09%
• 1Y: 12.40%
• 3Y*: 9.48%
• 5Y*: 2.13%
• 10Y*: 3.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MRSIX vs. MEDIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MRSIX MFS Research International Fund	8.90%	22.61%	3.06%	13.44%	-17.33%	11.87%	13.18%	27.98%	-13.98%	28.38%
MEDIX MFS Emerging Markets Debt Fund	2.46%	12.48%	5.92%	9.42%	-15.97%	-2.40%	8.01%	14.12%	-4.99%	9.64%

Correlation

The correlation between MRSIX and MEDIX is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.49
Correlation (3Y) Calculated over the trailing 3-year period	0.42
Correlation (5Y) Calculated over the trailing 5-year period	0.43
Correlation (10Y) Calculated over the trailing 10-year period	0.39
Correlation (All Time) Calculated using the full available price history since Mar 18, 1998	0.36

The correlation between MRSIX and MEDIX shifts across timeframes, from 0.36 (all time) to 0.49 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

MRSIX vs. MEDIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRSIX

MRSIX Risk / Return Rank: 17
MRSIX Sharpe Ratio Rank: 18
MRSIX Sortino Ratio Rank: 18
MRSIX Omega Ratio Rank: 18
MRSIX Calmar Ratio Rank: 15
MRSIX Martin Ratio Rank: 17

MEDIX

MEDIX Risk / Return Rank: 84
MEDIX Sharpe Ratio Rank: 94
MEDIX Sortino Ratio Rank: 96
MEDIX Omega Ratio Rank: 93
MEDIX Calmar Ratio Rank: 65
MEDIX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRSIX vs. MEDIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MFS Research International Fund (MRSIX) and MFS Emerging Markets Debt Fund (MEDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MRSIX	MEDIX	Difference
Sharpe ratio: Return per unit of total volatility	1.21	3.25	-2.04
Sortino ratio: Return per unit of downside risk	1.76	5.40	-3.64
Omega ratio: Gain probability vs. loss probability	1.22	1.70	-0.47
Calmar ratio: Return relative to maximum drawdown	1.37	3.09	-1.72
Martin ratio: Return relative to average drawdown	4.79	13.52	-8.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MRSIX vs. MEDIX - Sharpe Ratio Comparison

The current MRSIX Sharpe Ratio is 1.21, which is lower than the MEDIX Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of MRSIX and MEDIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MRSIX	MEDIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.21	3.25	-2.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.39	0.36	+0.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.57	0.64	-0.07
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.98	-0.59

Drawdowns

MRSIX vs. MEDIX - Drawdown Comparison

The maximum MRSIX drawdown since its inception was -59.56%, which is greater than MEDIX's maximum drawdown of -35.31%. Use the drawdown chart below to compare losses from any high point for MRSIX and MEDIX.

Drawdown Indicators

	MRSIX	MEDIX	Difference
Max Drawdown Largest peak-to-trough decline	-59.56%	-35.31%	-24.25%
Max Drawdown (1Y) Largest decline over 1 year	-11.64%	-4.12%	-7.52%
Max Drawdown (3Y) Largest decline over 3 years	-13.95%	-7.48%	-6.47%
Max Drawdown (5Y) Largest decline over 5 years	-30.73%	-27.40%	-3.33%
Max Drawdown (10Y) Largest decline over 10 years	-30.73%	-27.40%	-3.33%
Current Drawdown Current decline from peak	-1.90%	0.00%	-1.90%
Average Drawdown Average peak-to-trough decline	-12.75%	-4.44%	-8.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.34%	0.94%	+2.40%

Volatility

MRSIX vs. MEDIX - Volatility Comparison

MFS Research International Fund (MRSIX) has a higher volatility of 4.01% compared to MFS Emerging Markets Debt Fund (MEDIX) at 1.39%. This indicates that MRSIX's price experiences larger fluctuations and is considered to be riskier than MEDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MRSIX	MEDIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.01%	1.39%	+2.62%
Volatility (6M) Calculated over the trailing 6-month period	10.64%	3.22%	+7.42%
Volatility (1Y) Calculated over the trailing 1-year period	13.30%	3.92%	+9.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.92%	5.89%	+9.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.46%	5.87%	+9.59%

MRSIX vs. MEDIX - Expense Ratio Comparison

MRSIX has a 0.76% expense ratio, which is lower than MEDIX's 0.81% expense ratio.

Dividends

MRSIX vs. MEDIX - Dividend Comparison

MRSIX's dividend yield for the trailing twelve months is around 4.83%, less than MEDIX's 5.04% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MEDIX MFS Emerging Markets Debt Fund	5.04%	5.22%	5.68%	4.90%	5.51%	4.33%	4.07%	4.59%	4.87%	4.46%	4.86%	5.25%
MRSIX MFS Research International Fund	4.83%	5.26%	2.00%	1.67%	1.57%	1.29%	0.92%	1.79%	5.48%	1.21%	1.97%	1.89%

Frequently Asked Questions

Can I hold both MRSIX and MEDIX in my portfolio?

MRSIX and MEDIX have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MRSIX or MEDIX?

MRSIX has higher volatility (4.01%) compared to MEDIX (1.39%). In terms of maximum drawdown, MRSIX dropped -59.56% vs MEDIX's -35.31%.

Which has better risk-adjusted returns?

MEDIX currently has the higher Sharpe Ratio (3.25 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.